129 related articles for article (PubMed ID: 32870062)
41. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
Wall M
Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
[TBL] [Abstract][Full Text] [Related]
42. [Clinical analysis in a cohort of 102 patients with myelodysplastic syndrome characterized by erythroid hyperplasia].
Yu Y; Sun AN; Chen SN; Wang QR; Zhang TT; Wu DP
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):29-33. PubMed ID: 28056320
[No Abstract] [Full Text] [Related]
43. Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes.
Ai J; Visconte V; Tabarroki A; Hasrouni E; Hamilton BK; Mukherjee S; Kalaycio M; Sobecks R; Advani AS; Sekeres MA; Shetty S; Tiu RV
Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):489-95. PubMed ID: 25977195
[TBL] [Abstract][Full Text] [Related]
44. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.
Van Den Neste E; Robin V; Francart J; Hagemeijer A; Stul M; Vandenberghe P; Delannoy A; Sonet A; Deneys V; Costantini S; Ferrant A; Robert A; Michaux L
Leukemia; 2007 Aug; 21(8):1715-22. PubMed ID: 17541398
[TBL] [Abstract][Full Text] [Related]
45. [Progress of cytogenetic detection in myelodysplastic syndromes].
Zhou QB; Hu XM; Liu -; Ma R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1536-40. PubMed ID: 22169320
[TBL] [Abstract][Full Text] [Related]
46. Cytogenetics of myelodysplastic syndromes.
Mecucci C; La Starza R
Forum (Genova); 1999; 9(1):4-13. PubMed ID: 10101207
[TBL] [Abstract][Full Text] [Related]
47. Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality.
Rai S; Espinoza JL; Morita Y; Tanaka H; Matsumura I
Front Immunol; 2018; 9():3031. PubMed ID: 30687305
[TBL] [Abstract][Full Text] [Related]
48. Frequent chromatin rearrangements in myelodysplastic syndromes--what stands behind?
Pagáčová E; Falk M; Falková I; Lukášová E; Michalová K; Oltová A; Raška I; Kozubek S
Folia Biol (Praha); 2014; 60 Suppl 1():1-7. PubMed ID: 25369334
[TBL] [Abstract][Full Text] [Related]
49. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
Cao P; Li Y; Li X; Zhang G; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
[TBL] [Abstract][Full Text] [Related]
50. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
51. Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.
Horai M; Satoh S; Matsuo M; Iwanaga M; Horio K; Jo T; Takasaki Y; Kawaguchi Y; Tsushima H; Yoshida S; Taguchi M; Itonaga H; Sawayama Y; Taguchi J; Imaizumi Y; Hata T; Moriuchi Y; Haase D; Yoshiura KI; Miyazaki Y
Br J Haematol; 2018 Feb; 180(3):381-390. PubMed ID: 29265181
[TBL] [Abstract][Full Text] [Related]
52. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
[TBL] [Abstract][Full Text] [Related]
53. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
Panani AD; Pappa V
In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
[TBL] [Abstract][Full Text] [Related]
54. Monosomal karyotype of chromosome 5/7 was an independent poor prognostic factor for Chinese myelodysplastic syndrome patients.
Zhang T; Xu Y; Pan J; Qiu H; Wu D; Chen S; Sun A
Cancer Genet; 2016 Sep; 209(9):423-429. PubMed ID: 27423487
[TBL] [Abstract][Full Text] [Related]
55. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
[TBL] [Abstract][Full Text] [Related]
56. New recurrent chromosome change in pediatric therapy-related myelodysplastic syndrome: unbalanced translocation 1/6 with cryptic duplication of short arm of chromosome 6.
Tassano E; Tavella E; Valli R; Micalizzi C; Cuoco C; Maserati E; Pasquali F; Morerio C
Leuk Lymphoma; 2012 Dec; 53(12):2434-8. PubMed ID: 22616618
[TBL] [Abstract][Full Text] [Related]
57. Jumping translocations: Short telomeres or pathogenic TP53 variants as underlying mechanism in acute myeloid leukemia and myelodysplastic syndrome?
Behrens YL; Thomay K; Hagedorn M; Ebersold J; Schmidt G; Lentes J; Davenport C; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2019 Mar; 58(3):139-148. PubMed ID: 30614587
[TBL] [Abstract][Full Text] [Related]
58. [Chromosomal aberrations in myelodysplastic syndrome].
Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
[TBL] [Abstract][Full Text] [Related]
59. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
[TBL] [Abstract][Full Text] [Related]
60. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
